Showing Form 4 filings for KURA
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Kura Oncology, Inc.
Price
$10.67
Shares
41,250
Ownership
141,095
Value/Share
Leoni Mollie
Chief Medical Officer
Industry
$10.63
32,450
136,819
Powl Brian T.
Chief Commercial Officer
$10.59
10,574
142,986
Ford Kathleen
COO
$10.50
8,442
187,002
Bair Teresa Brophy
GC
4,607
142,928
Doyle Thomas James
SVP, Finance, Accounting